Institute of Oncology Ljubljana Leverages SOPHiA DDM™ Platform for Cancer Research

In order to advance its clinical oncology research, IOL is leveraging low-pass Whole Genome Sequencing data computed by the proprietary GIInger deep-learning algorithm from SOPHiA GENETICS to increase research efficiency and obtain actionable clinical insights to make data-driven decisions that improve the quality of patient care.

Access the full article to read more here.